ResearcherOblikue Consulting (Spain)No recent work listed

Ferran Pérez-Alcántara

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5039290266. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2015: 1 paper

Papers 1

Cost-utility analysis of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in combination with gemcitabine in metastatic pancreatic cancer in Spain: resul… Last author DOI 10.1586/14737167.2015.1047349 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Fernando Rivera · 1 shared paper, 2015 · strength 0.05
- Paper Cost-utility analysis of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in combination with gemcitabine in meta… DOI 10.1586/14737167.2015.1047349 ↗
Alfredo Carrato · 1 shared paper, 2015 · strength 0.05
- Paper Cost-utility analysis of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in combination with gemcitabine in meta… DOI 10.1586/14737167.2015.1047349 ↗
Rafael López‐López · 1 shared paper, 2015 · strength 0.05
- Paper Cost-utility analysis of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in combination with gemcitabine in meta… DOI 10.1586/14737167.2015.1047349 ↗
Teresa Mercade Macarulla · 1 shared paper, 2015 · strength 0.05
- Paper Cost-utility analysis of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) in combination with gemcitabine in meta… DOI 10.1586/14737167.2015.1047349 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.